Northern Trust’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-723
Closed -$7.84K 4622
2022
Q4
$7.84K Sell
723
-1
-0.1% -$14 ﹤0.01% 4597
2022
Q3
$15K Hold
724
﹤0.01% 4593
2022
Q2
$29K Sell
724
-22
-3% -$1.01K ﹤0.01% 4563
2022
Q1
$42K Buy
746
+22
+3% +$1.05K ﹤0.01% 4573
2021
Q4
$30K Hold
724
﹤0.01% 4670
2021
Q3
$60K Hold
724
﹤0.01% 4506
2021
Q2
$86K Hold
724
﹤0.01% 4402
2021
Q1
$80K Buy
724
+229
+46% +$28.1K ﹤0.01% 4320
2020
Q4
$50K Sell
495
-38
-7% -$4.64K ﹤0.01% 4238
2020
Q3
$60K Buy
533
+75
+16% +$10.1K ﹤0.01% 4080
2020
Q2
$69K Sell
458
-12
-3% -$1.87K ﹤0.01% 3993
2020
Q1
$54K Hold
470
﹤0.01% 3942
2019
Q4
$103K Buy
+470
New +$94.3K ﹤0.01% 3932
2018
Q1
Sell
-20
Closed -$4K 4274
2017
Q4
$4K Hold
20
﹤0.01% 4215
2017
Q3
$7K Hold
20
﹤0.01% 4213
2017
Q2
$7K Hold
20
﹤0.01% 4235
2017
Q1
$11K Buy
+20
New +$14.4K ﹤0.01% 4189
2016
Q2
Sell
-87
Closed -$194K 4261
2016
Q1
$194K Hold
87
﹤0.01% 3744
2015
Q4
$212K Hold
87
﹤0.01% 3753
2015
Q3
$213K Buy
+87
New +$362K ﹤0.01% 3720

Other funds holding RKDA

Northern Trust's RKDA Position: Q1 2023 in Review

Northern Trust sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 723 shares — an estimated $7.84K sold.

Northern Trust first reported a position in RKDA in Q3 2015 and held it in 20 quarters. The position peaked at $213K in Q3 2015. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • Northern Trust reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 723 Arcadia Biosciences shares in Q1 2023, an estimated $7.84K.
  • Northern Trust first reported a position in Arcadia Biosciences in Q3 2015 and held it in 20 quarters.
  • Northern Trust's Arcadia Biosciences position peaked at $213K in Q3 2015.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.